Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. It is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. It makes products for use across many industries, including healthcare, industrial chemicals, agriculture and academic research.
Mã chứng khoánTWST
Tên công tyTwist Bioscience Corp
Ngày IPOOct 31, 2018
Giám đốc điều hànhDr. Emily M. Leproust, Ph.D.
Số lượng nhân viên923
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhOct 31
Địa chỉ681 Gateway Blvd.
Thành phốSOUTH SAN FRANCISCO
Sàn giao dịch chứng khoánNASDAQ Global Select Consolidated
Quốc giaUnited States of America
Mã bưu điện94080
Điện thoại18007190671
Trang webhttps://www.twistbioscience.com/
Mã chứng khoánTWST
Ngày IPOOct 31, 2018
Giám đốc điều hànhDr. Emily M. Leproust, Ph.D.
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu